Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cronos Group Inc T.CRON

Alternate Symbol(s):  CRON

Healthcare Cannabis
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is... see more

Recent & Breaking News (TSX:CRON)

Cronos Grants Stock Options

MarketWire Canada April 12, 2017

Cronos Execs On Marijuana Legalization In Canada And How It Affects The Co: Market Could Be Ready To Go By 2019

Benzinga.com  March 21, 2017

Cronos Group Execs Discuss The Challenges Of Exporting Cannabis As An Insurance-Reimbursed Product

Benzinga.com  March 19, 2017

Cronos Group Execs Talk About Cannabis Co., Recent 'Bought Deal' And Expansion Plans

Benzinga.com  March 18, 2017

Cronos Re-Invests in Whistler as Part of Transformative Expansion

Canada NewsWire March 9, 2017

Cronos Group Announces Closing of Previously Announced $17 Million Bought Deal

MarketWire Canada March 9, 2017

Cronos Announces Re-Filing of Management's Discussion and Analysis for the Period Ended September 30, 2016

MarketWire Canada March 2, 2017

Cronos Recognized as Top TSX Venture 50 Performer

Canada NewsWire February 27, 2017

IIROC Trading Resumption - MJN

Canada NewsWire February 14, 2017

IIROC Trade Resumption - PharmaCan Capital Corp.

Newsfile February 14, 2017

PharmaCan Capital Announces $15 Million Bought Deal

MarketWire Canada February 14, 2017

IIROC Trading Halt - MJN

Canada NewsWire February 14, 2017

IIROC Trade Halt - PharmaCan Capital Corp.

Newsfile February 14, 2017

Licensed Cannabis Producer Cronos Group Receives Buy Recommendation from PI Financial - Video Available on InvestmentPitch.com

Newsfile February 3, 2017

Cronos Calls Shareholder Meeting to Formalize Name Change

MarketWire Canada January 23, 2017

Cronos Applauds German Legalization of Medical Cannabis

MarketWire Canada January 19, 2017

Cronos Group Granted Second Health Canada Sales License

MarketWire Canada January 11, 2017

Cronos Enters Exclusive European Supply Agreement with Pedanios

Marketwired December 28, 2016

Viridian Experts Talk Recent Cannabis Industry Deals: M&A, Capital Raises And IPOs

Benzinga.com  December 16, 2016

Cronos Embraces Legalization Task Force Report

MarketWire Canada December 13, 2016